3F12 | pdb_00003f12

Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.95 Å
  • R-Value Free: 
    0.320 (Depositor) 
  • R-Value Work: 
    0.300 (Depositor), 0.297 (DCC) 
  • R-Value Observed: 
    0.320 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 3F12

This is version 1.3 of the entry. See complete history

Literature

Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus.

Thomson, C.A.Bryson, S.McLean, G.R.Creagh, A.L.Pai, E.F.Schrader, J.W.

(2008) EMBO J 27: 2592-2602

  • DOI: https://doi.org/10.1038/emboj.2008.179
  • Primary Citation Related Structures: 
    3EYF, 3EYO, 3EYQ, 3F12

  • PubMed Abstract: 

    Immunoglobulin genes are generated somatically through specialized mechanisms resulting in a vast repertoire of antigen-binding sites. Despite the stochastic nature of these processes, the V-genes that encode most of the antigen-combining site are under positive evolutionary selection, raising the possibility that V-genes have been selected to encode key structural features of binding sites of protective antibodies against certain pathogens. Human, neutralizing antibodies to human cytomegalovirus that bind the AD-2S1 epitope on its gB envelope protein repeatedly use a pair of well-conserved, germline V-genes IGHV3-30 and IGKV3-11. Here, we present crystallographic, kinetic and thermodynamic analyses of the binding site of such an antibody and that of its primary immunoglobulin ancestor. These show that these germline V-genes encode key side chain contacts with the viral antigen and thereby dictate key structural features of the hypermutated, high-affinity neutralizing antibody. V-genes may thus encode an innate, protective immunological memory that targets vulnerable, invariant sites on multiple pathogens.


  • Organizational Affiliation
    • The Biomedical Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.

Macromolecule Content 

  • Total Structure Weight: 99.13 kDa 
  • Atom Count: 6,303 
  • Modeled Residue Count: 825 
  • Deposited Residue Count: 916 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
M2J1 Fab
A, C
216Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
8f9 Fab
B, D
242Homo sapiensMutation(s): 0 

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.95 Å
  • R-Value Free:  0.320 (Depositor) 
  • R-Value Work:  0.300 (Depositor), 0.297 (DCC) 
  • R-Value Observed: 0.320 (Depositor) 
Space Group: P 32 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 87.86α = 90
b = 87.86β = 90
c = 241.85γ = 120
Software Package:
Software NamePurpose
HKL-2000data collection
PHASERphasing
CNSrefinement
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2009-09-15
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2023-09-06
    Changes: Data collection, Database references, Refinement description
  • Version 1.3: 2024-10-30
    Changes: Structure summary